Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Authors
Posts by Firstwordpharma News
Firstwordpharma News
1880 POSTS
0 COMMENTS
Immuno-oncology
Activation of a distinct genetic pathway can slow the progress of...
Firstwordpharma News
-
January 17, 2020
0
Others
A New Therapy for Spinal Cord Injury
Firstwordpharma News
-
January 17, 2020
0
Others
Court to Look Anew at Health Care Law Birth Control Rules...
Firstwordpharma News
-
January 17, 2020
0
Others
Do You Take Warfarin? Time of Day Might Not Matter ...
Firstwordpharma News
-
January 17, 2020
0
Others
Biocon plans to halve insulin prices ...
Firstwordpharma News
-
January 17, 2020
0
1
2
3
...
376
Page 1 of 376
- Advertisement -
MOST POPULAR
Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on...
July 1, 2019
Aduro Biotech Abstracts Accepted for Presentation at the 2019 American Society...
April 17, 2019
Your Feedback Matters! Biopharma Career Growth
December 19, 2019
After Cancer Drug Fails Pancreatic Cancer Trial, Lilly Plans to Continue...
October 17, 2019
Load more
HOT NEWS
Commercial
DNV3681’s exceptional activity against bioterrorist threats presented at ASM Microbe 2019
Deals
Invenra and WARF Initiate a Collaboration to Discover and Develop Novel...
Phase III
Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206...
Commercial
GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma,...
